Guest guest Posted February 23, 1999 Report Share Posted February 23, 1999 Greetings List: For information of others on the list here are 3 articles that explain migraine headache relief. McGrady A et al : Effect of biofeedback-assisted relaxation on migraine headache and changes in cerebral blood flow velocity in the middle cerebral artery. McGrady A et al: Effect of biofeedback-assisted relaxation on migraine headache and changes in cerebral blood flow velocity in the middle cerebral artery. Headache, 34(7):424-428, 1994. 14 References Dept. of Psychiatry, Medical College of Ohio, PO Box 10008, Toledo, OH 43699-0008 (Ms A McGrady, Ph.D.) JAC.08 DC9409/339 © 1994 This study examined the effects of thermal biofeedback-assisted relaxation on migraine headache (HA) pain and medication use. It also examined whether there is a relationship between central blood flow (CBF) velocity in the middle cerebral artery (MCA), and improvement of HA mediated by biofeedback-assisted relaxation. Two types of relaxation were involved in migraine patients: one was biofeedback-assisted relaxation therapy and the other was a self-relaxation control. Assessments were made of HA pain, medication use, and CBF velocity of the MCA before and after treatment. A total of 23 migraine HA patients volunteered for the study. They were mailed HA log sheets to record the intensity, frequency, and duration of HAs, and prescription and over-the-counter medication use for a 15-24 day period before group assignments were given. Patients reported the use of analgesics, antidepressants, non-steroidal anti-inflammatory drugs, and calcium channel blockers. At the first visit, patients completed a medical history questionnaire on their HAs, other medical problems, and general health habits, eg, smoking, exercise, and caffeine use. Forehead muscle measurements, electromyographs (EMGs), and finger temperatures were recorded during a 15 min period with the patient reclining with their eyes closed. CBF was measured in the left and right MCA with a transcranial Doppler. Psychological measurements included anxiety and depression tests administered pre- and post-test. Patients were randomly assigned to one of two groups following pre-tests: the experimental (EXP) group (n = 11) and control (CON) group (n = 12). The EXP group underwent 12 sessions of biofeedback (4 EMG biofeedback and 8 temperature biofeedback) over a 12 wk period. EMG feedback from the forehead muscles was added to relaxation because excessive contraction of facial and head muscles may contribute to HAs. Autogenic relaxation was presented at the first treatment session. Two 10-15 min daily at-home practice periods using taped autogenic relaxation were recommended. During treatments, patients were trained to decrease forehead muscle tension and to increase finger temperature with feedback and autogenic relaxation. The CON group (self-relaxation) was told to relax on their own for 10-15 mins. bid, concentrating on peaceful thoughts or on their breathing. No tapes or scripts were used. This group was seen twice during the 12 wk period. Both groups continued to monitor HA pain and medication use. At the conclusion of the study, both groups returned for post-test measurements. For another 6 wks., patients were asked to monitor their HAs and the information was included. The data was analyzed and success was defined as 50% reduction in pain score. The EXP group lowered forehead muscle tension and increased finger temperature, whereas the CON group did not. The EXP group decreased pain by 35%. Six of eleven patients decreased pain by more than 50%. The CON group increased pain by 7.7%; three of twelve patients decreased pain by 50%. In the EXP group, no patients increased medication intake, whereas nine decreased. In the CON group, four patients increased medication, while only five decreased. The group difference in medication change between pre- and post-test was significant. The MCA blood flow data revealed that the EXP group decreased peak systolic velocity and mean blood flow velocity on both the right and the left sides. The CON group decreased peak systolic velocity and mean blood flow velocity slightly on the right side and increased on the left side. Of the eleven patients in the EXP group, nine had a left/right difference in peak systolic velocity of > 10 cm/sec in comparison to three of eleven in the CON group (CBF on the right could not be determined in one patient). The anxiety and depression measurements showed decreases in all measures in both groups. Pain scores in the EXP group showed a decrease from 1.09 at pre-test to 0.86 at post-test, with a further decrease to 0.42 at follow-up. The percentage of success (60%) was identical at post-test and follow-up. Ten patients reported continuing their practice of autogenic relaxation at least once a day. The results show that the biofeedback-assisted relaxation therapy was superior to the self-relax in pain and medication reduction. Fifty-five percent of the EXP group and 25% of the self-relax group met criteria for success. Decreases in all types of medication use supported the reductions in HA intensity, duration, and frequency. Follow-up data suggest persistence of the success of the treatment for 4-6 wks.. Evidence from other studies suggests success lasts for several yrs.. Of special interest is the suggestion that a higher blood flow velocity (related to vasoconstriction of the MCA or vasodilation in the arterioles) exists on one side of the head in migraineurs even during the interictal period. In fact, the EXP group significantly reduced peak systolic velocity and mean CBF velocity on the side with the highest velocity. Interpretations of this data are limited. However, future studies will include measurements of CBF velocity in other intracranial vessels where abnormalities in flow may be related to migraine. 2 Blanchard EB et al : The role of perception of success in the thermal biofeedback treatment of vascular headache. Blanchard EB et al: Headache Quarterly, 5(4):231-236, 1994. 12 References Center for Stress and Anxiety Disorders, University at Albany, 1535 Western Ave., Albany, NY 12203 (Dr EB Blanchard) DN.03 MY9528/148 ©1995 Biofeedback is a popular, well-accepted form of non-drug treatment for chronic headache (HA) which consistently leads to meaningful improvement in 40-80% of patients. The most widely accepted explanations for these improvements posit that the benefits are the result of patients' learning to control peripheral responses which mediate the physiological pathway of the HA (increased muscle tension in tension HA; peripheral vasoconstriction and vasodilation in vascular HA). The participants in this research were 28 chronic vascular HA patients (15 with migraine and 13 with combined migraine and tension HA), average age 38.5 yrs., who had an average 16.9 yr. history of HAs. There were four males and 24 females. The patients were started in a HA diary in which they recorded level of HA activity on a zero (no HA) to five (intense, incapacitating HA) scale four times a day. They also recorded all medications taken. The diary was continued throughout treatment, and for a four week post treatment observation period. All participants received 12 sessions of thermal biofeedback (TBF) for hand warming, spread over approximately six wks.. At the initial session, a rationale for the hand-warming treatment was given which emphasized the prophylactic effects of learning the hand-warming. The patients were given the positive expectancy that learning the hand warming response would lead to a decrease in HA activity. Patient's expectations of relief of HAs were assessed by questionnaires. All biofeedback sessions had the same format. After attaching the temperature sensor to the dorsal surface of the most distal phalanx of the left index finger, a 3-7 min adaptation phase followed. Next was a 4 min in-session baseline during which the patient sat quietly. Next followed a 4 min self-control phase during which the patient was to warm his or her hand without the benefit of feedback. Finally, there was a 16 min feedback trial during which feedback was available and the patient was asked to warm his or her hand as much as possible. The average baseline temperature and the highest temperature in self-control or during feedback training were recorded. The primary independent variable was the manipulation of the participant's attributions about how successful she/he was at biofeedback. Attributions were manipulated by computer and given to the patient at the end of each session. The printout compared the patient's performance to other similar HA patients. For the patients in the high success condition, by the third session, they were depicted as performing at an average percentile value of 80%. For the modest success condition, values averaged about the 50th percentile. For the subjects in the high success condition, increases in temperature were doubled while decreases were halved. For the subjects in the modest success condition, increases in temperature were halved, while decreases were unaffected; therefore, the biofeedback was accurate in reflecting changes and correctly indicating direction of change. The HA index was calculated by summing four ratings/day times seven days and dividing by seven to get an average HA index for the week. This value incorporates intensity and duration and was considered most sensitive. For the medication index, each medication was " scaled " and multiplied by the number of doses taken, to represent the level of weekly HA medication consumption. There was significant reduction in HA activity and a trend for the attributional manipulation to lead to differential HA relief. These results confirm our previous finding (Blanchard et al, 1991) that thermal biofeedback for hand-warming, can lead to significant reduction in the HA activity of vascular HA sufferers. Our main difficulty in this study was that a sizable minority of the vascular HA patients in the modest-success condition thought they were doing very well. This could be because they were experiencing success at the hand warming task, which is inherent in the biofeedback treatment. We believe that some of the HA relief experienced by vascular HA patients receiving thermal biofeedback is due to the inherent success experience built into the task and to its consequent effects on patients' self-efficacy. Vijayan N: Head band for migraine headache relief. Headache, 33(1):40-42, 1993. 6 References Headache & Neurology Clinic, 1020 29th Street, #360, Sacramento, CA 95816 (Dr N Vijayan) JAC.04A 184.1 7/93 © 1991 Abortive therapy of migraine headache (HA) is usually achieved by the use of vasoconstrictor agents, analgesics, sedation, and anti-emetic agents. Various non-pharmacological methods have also been tried in the past, ice pack being the most common of these procedures. Some patients have also reported relief from hot baths or hot packs applied to the neck and scalp. A large number of patients reported using finger pressure in the temporal region for temporary pain relief. One hundred consecutive patients with a diagnosis of migraine HA with and without aura were interviewed. Ninety-two percent of these patients had attempted some type of local measure in an attempt to control the pain; 85% used finger pressure, a tight towel, or a piece of clothing around the head. Seventy-five percent of those using these techniques reported some degree of relief of pain as long as the pressure was maintained. Pressure was applied over the area of maximum pain, with 90% applying pressure over one or both temporal regions, 5% in the sub-occipital regions, and the rest over the forehead. Those who used finger pressure often sought the help of other family members to help them with continued application of pressure. After several attempts at designing a pressure band for the head, it was found that a firm rubber disc 1 cm thick and 3 cm in diameter inserted under an elastic band (4-5 cm wide and 60-65 cm long) and secured with Velcro was effective in applying desired localized pressure. One or more of the rubber discs could be used. Twenty-five patients with a diagnosis of migraine with and without aura, according to criteria established by the Headache Classification Committee of the International Headache Society, were tested with these bands. A pain log of 0-10 was used to assess the severity of pain. The band and the discs were applied when the pain reached > 5 on the pain scale. The amount of pressure applied was determined by the patient to obtain maximum relief without discomfort, and one or more discs were used over the maximum pain areas. Pain was assessed at 10 min intervals for 30 mins.. The band was then released and pain severity was assessed every 10 mins for 30 mins. Each patient used the band during three HAs. No analgesics or vasoconstrictors were allowed for the duration of 60 mins.. Two patients could not apply adequate pressure because of tenderness of the scalp and did not remain in the study. Twenty-three remaining patients used the band in a total of 69 HAs for which data was collected. HA relief was reported in 60 HAs (87%). There was no improvement in nine HAs (13%). Of the 60 HAs which improved, 40 HAs (67%) decreased by over 80%, 15 HAs (25%) improved between 50-60%, and 5 HAs (8%) showed < 50% improvement. All 23 patients continued to use the band as an adjunct to other therapy during the initial follow-up period of 6 mos. A simple elastic band applied around the head and secured with Velcro, along with the use of rubber discs inserted beneath the band for additional local pressure over maximum pain areas, appears to be beneficial for temporary and partial control of migraine pain, and is effective as an adjuvant with use of analgesics and vasoconstrictors. The exact mechanism of this remains unknown. Peace & Blessings D. -- ---------------------------------------------------- Reach me by ICQ. My ICQ# is 24385601 or, Page me online through my Personal Communication Center: http://wwp.mirabilis.com/24385601 (go there and try it!) or, Send me E-mail Express directly to my computer screen 24385601@... For downloading ICQ at http://www.icq.com/ For adding similar signatures to your e-mail go to : http://www.icq.com/emailsig.html E.Darwent ---------------------------------------------------- Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.